Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 0.56 |   |
Earnings Per Share | -$0.37 |   |
Price To Sales Ratio | N/A | |
Price To Book Ratio | 2.10 |   |
Price To Tangible Book Ratio | 2.49 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 14.0M |   |
Float (MRQ) | 76.79% |   |
Shares Outstanding (MRQ) | 30.4M |   |
Short Interest as a % of Float (MRQ) | 1.96% |   |
Shares Held By Institutions (MRQ) | 1.5M |   |
Margins | Industry Range | |
---|---|---|
Sales | $0.00 |   |
Gross Margin | N/A | |
Net Profit Margin | N/A | |
EBIT Margin | N/A | |
EBITDA Margin | N/A | |
Operating Margins | N/A |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 19.61 |   |
Quick Ratio (MRQ) | 19.61 |   |
Total Debt/Equity Ratio (MRQ) | 0.32 |   |
Debt/Common Equity Ratio (MRQ) | 0.32 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -52.54% |   |
Return on Assets | -59.68% |   |
Asset Turnover | 0.00 |   |
Receivables Turnover | N/A | |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | -64.36% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*ARTL does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.18%